Article
Genetics of drug-induced liver injury: Current knowledge and future prospects.
Clinical and translational science - 1 Jan 2023
Daly Ann K
Abstract excerpt
Idiosyncratic drug-induced liver injury (DILI) remains an important clinical problem, both during drug development and the prescription of a range of licensed drugs. Although rare, the consequences are serious. Ongoing studies on genetic risk factors for DILI, especially genomewide association studies, have resulted in the identification of a number of genetic risk factors, including particular HLA alleles and a...
Topics
Join the communities discussing this publication.